🇺🇸 FDA
Pipeline program

Padcev 30 mg powder for concentrate for solution for infusion, Bavencio 20 mg/mL concentrate for solution for infusion

UKT-IKF-DEPECA-1

Phase 2 small_molecule active

Quick answer

Padcev 30 mg powder for concentrate for solution for infusion, Bavencio 20 mg/mL concentrate for solution for infusion for locally advanced or metastatic penile squamous cell carcinoma is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
locally advanced or metastatic penile squamous cell carcinoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials